Clinical trial
Epigenetic Markets in Growth Restricted Human Pregnancies: A Case- Control Study
NCT00510380 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epigenetic Markets in Growth Restricted Human Pregnancies: A Case- Control Study
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- April 30, 2009
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.